======= VWA9 ======= == Gene Information == * **Official Symbol**: INTS14 * **Official Name**: integrator complex subunit 14 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81556|81556]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96SY0|Q96SY0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VWA9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VWA9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620878|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Probable component of the Integrator (INT) complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. {ECO:0000250|UniProtKB:Q9VPY0}. No Pfam Domain information is available for this gene. |integrator complex| |snRNA 3-end processing| |snRNA processing| |snRNA metabolic process| |ncRNA 3-end processing| |snRNA transcription by RNA polymerase II| |snRNA transcription| |ncRNA transcription| |RNA 3-end processing| |ncRNA processing| |ncRNA metabolic process| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |RNA processing| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|-1.81| |[[:results:exp211|AICAR 240μM R05 exp211]]|1.72| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|1.82| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.95| |[[:results:exp134|MS023 2μM R03 exp134]]|1.99| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|2.04| ^Gene^Correlation^ |[[:human genes:i:ints10|INTS10]]|0.661| |[[:human genes:c:c7orf26|C7orf26]]|0.62| |[[:human genes:a:asun|ASUN]]|0.602| Global Fraction of Cell Lines Where Essential: 46/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|0/28| |bone|2/26| |breast|6/33| |central nervous system|8/56| |cervix|0/4| |colorectal|3/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|1/21| |liver|3/20| |lung|4/75| |lymphocyte|1/16| |ovary|1/26| |pancreas|1/24| |peripheral nervous system|1/16| |plasma cell|2/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|2/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1930 * **Expression level (log2 read counts)**: 6.21 {{:chemogenomics:nalm6 dist.png?nolink |}}